News
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...
Novartis on Tuesday said it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...
A study shows that the health of U.S. children has deteriorated over the last 17 years, with kids today more likely to ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
Brain differences in children and teens who experiment with drugs early show up before they take their first puff or sip ...
But now is not the time to retreat into our homes to "protect" our children, pediatrician Dr. Christopher Forrest told ...
The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.
20h
Pharmaceutical Technology on MSNFDA approves KalVista’s Ekterly for hereditary angioedemaThe US Food and Drug Administration (FDA) has approved KalVista Pharmaceuticals' Ekterly (sebetralstat) as the first and only ...
After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results